Literature DB >> 24217817

Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome.

Rong Kun Han1, Yue Feng Cheng, Shan Shan Zhou, Hong Guo, Rui Dong He, Li Jun Chi, Li Ming Zhang.   

Abstract

PURPOSE: Guillain-Barré syndrome (GBS) is an acute post-infectious immune-mediated demyelinating disease of the peripheral nervous system. Th17 cells and osteopontin (OPN) have been implicated in the development of autoimmune diseases, but little is known about their relationship and roles in the pathogenesis of GBS.
METHODS: In this study, we used flow cytometry to evaluate peripheral numbers of Th17, real-time polymerase chain reaction to assay mRNA expression of RORγt, and enzyme-linked immunosorbent assay to determined OPN and IL-17 concentrations.
RESULTS: The frequency of Th17 cells was significantly higher in the peripheral blood of acute-stage GBS patients comparison with other non-inflammatory neurological diseases (OND). In line with these observations, the levels of mRNA expression of RORγt in peripheral blood mononuclear cells and the concentrations IL-17 in both plasma and cerebrospinal fluid (CSF) were significantly higher in the acute-stage GBS than stable-stage GBS. OPN concentrations were significantly increased in the CSF of acute-stage GBS patients compared to OND. Circulating Th17 cell populations and CSF OPN levels, respectively, are correlated with GBS disability scale scores (GDSs), and there was a positive correlation between them.
CONCLUSION: In summary, our preliminary findings suggest that both Th17 and OPN may be associated with the pathogenesis of GBS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217817     DOI: 10.1007/s10875-013-9965-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  41 in total

1.  Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody.

Authors:  N Yuki; K Susuki; K Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

2.  Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis.

Authors:  Guangjie Chen; Xin Zhang; Runsheng Li; Lei Fang; Xiaoyin Niu; Yingxia Zheng; Dongyi He; Rong Xu; Jingwu Z Zhang
Journal:  Arthritis Rheum       Date:  2010-10

3.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  Increased expression of osteopontin in the spinal cords of Lewis rats with experimental autoimmune neuritis.

Authors:  Changjong Moon; Taekyun Shin
Journal:  J Vet Sci       Date:  2004-12       Impact factor: 1.672

Review 5.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

6.  Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.

Authors:  A Créange; L Bélec; B Clair; J C Raphaël; R K Gherardi
Journal:  J Neuroimmunol       Date:  1996-08       Impact factor: 3.478

7.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

8.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

9.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  14 in total

1.  Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies.

Authors:  Nurcan Üçeyler; Nadja Riediger; Waldemar Kafke; Claudia Sommer
Journal:  J Neurol       Date:  2014-11-05       Impact factor: 4.849

Review 2.  An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.

Authors:  Marwa Kaisey; Ghazal Lashgari; Justyna Fert-Bober; Daniel Ontaneda; Andrew J Solomon; Nancy L Sicotte
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-21       Impact factor: 6.030

Review 3.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

4.  Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.

Authors:  Samantha S Soldan; Chenhe Su; R Jason Lamontagne; Nicholas Grams; Fang Lu; Yue Zhang; James D Gesualdi; Drew M Frase; Lois E Tolvinski; Kayla Martin; Troy E Messick; Jonathan T Fingerut; Ekaterina Koltsova; Andrew Kossenkov; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-06-09       Impact factor: 6.823

5.  Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis.

Authors:  Feng Jing; Fei Yang; Fang Cui; Zhaohui Chen; Li Ling; Xusheng Huang
Journal:  Biosci Rep       Date:  2017-07-16       Impact factor: 3.840

6.  Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.

Authors:  Lourdes Mateos-Hernández; Margarita Villar; Ernesto Doncel-Pérez; Marco Trevisan-Herraz; Ángel García-Forcada; Francisco Romero Ganuza; Jesús Vázquez; José de la Fuente
Journal:  Oncotarget       Date:  2016-11-15

Review 7.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818

8.  Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis.

Authors:  Shuping Liu; Yin Liu; Zheman Xiao; Sijia Pan; Qiaoyu Gong; Zuneng Lu
Journal:  Brain Behav       Date:  2019-11-19       Impact factor: 2.708

Review 9.  Guillain-Barré syndrome associated with Covid-19: A close relationship or just a coincidence? (Review).

Authors:  Adina Stoian; Rodica Bălașa; Bianca Liana Grigorescu; Smaranda Maier; Sebastian Andone; Iuliu Gabriel Cocuz; Zoltan Bajko; Cristian Rares Filep; Mircea Stoian
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 10.  Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.

Authors:  Elmira Agah; Arshia Zardoui; Amene Saghazadeh; Mona Ahmadi; Abbas Tafakhori; Nima Rezaei
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.